New Promega Maxwell® 16 LEV Blood DNA Kit Surpasses Concentration Standards in Less Time
April 21, 2010
MADISON, Wis.--Promega Corporation now offers the Maxwell® 16 LEV Blood DNA Kit which is designed to purify DNA from whole blood. The new kit, optimized to work on the Maxwell® 16 instrument, eliminates the need for a buffy coat step while providing exponentially higher concentration in less time with parallel purity. “The Promega LEV Blood [...]
bioMerieux and Knome Sign Strategic Partnership
April 21, 2010
Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market bioMerieux takes equity stake in Knome MARCY L'ETOILE, France and CAMBRIDGE, Mass. -- bioMerieux and Knome announced today that they have entered into a strategic agreement to collaborate in the development of next-generation, sequence-based in vitro diagnostics. Under the agreement, bioMerieux [...]
April 21, 2010
High Shear Processing Leader Applies For Microfluidics Reaction Technology™ (MRT) Patent in Japan Newton, MA (PRWEB) -- Microfluidics International Corporation (OTCBB: MFLU) today announced that, along with its exclusive Japanese distributor, POWREX Corporation, it has introduced Microfluidics Reaction Technology (MRT) to Japan as the world's only viable large-scale, bottom-up technology for nanoparticle creation. MRT is [...]
SAFC Hitech(R) Appoints Philip Rose as New President; Sees Great Opportunity in Electronics Industry
April 21, 2010
ST. LOUIS -- SAFC Hitech®, a business segment within SAFC®, a member of the Sigma-Aldrich® Group (NASDAQ:SIAL) , today announced the appointment of Philip Rose as its new company president succeeding Barry Leese, who retired on April 1, 2010. Rose will be based at SAFC Hitech's Haverhill, MA, facility, and joins the company after 20 [...]
April 21, 2010
BERGISCH GLADBACH, Germany--RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Energy & Supercon Technologies (BEST), Inc., today announced the award of a $7.7 million contract from the U.S. Department of Energy’s Brookhaven National Laboratory. The contract is for the turn-key supply of a 200 MeV electron injection linear accelerator for BNL’s next-generation National Synchrotron [...]
Ligand Earns $6.5 Million Milestone Payment from Roche
April 20, 2010
Roche Advances RG7348 into Clinical Development for Hepatitis C SAN DIEGO--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it earned a $6.5 million payment from Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY) as a result of Roche progressing RG7348 into a Phase I clinical trial for the treatment of hepatitis C viral (HCV) infection. The milestone [...]
Pall’s New Immobilized Carbon Depth Filters Expand Bioprocess Scale-Up Options
April 20, 2010
PORT WASHINGTON, NY -- Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, has launched Supra™ AKS depth filters for biotechnology and pharmaceutical purification applications. The new intermediate-size cartridges give process developers important new scale-up options when using Pall’s line of depth filters featuring Seitz® AKS immobilized activated carbon depth filter media. [...]
April 20, 2010
PORT WASHINGTON, NY -- Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, has introduced Pall T-Series cassettes for use in tangential flow filtration (TFF) applications. The new cassettes feature significant design enhancements while utilizing the same proven membranes to reduce revalidation requirements. T-series cassettes have been designed with more durable and [...]
Porvair Filtration Group Increases Focus On Single Brand Identity
April 20, 2010
Porvair Filtration Group has announced that its operating divisions - Porvair Technology, MF&T, Filters for Industry, Microfiltrex, and its US operation (formally Omnifilter and Manufacturing Inc.) will increasingly focus on trading under a single corporate brand - Porvair Filtration Group. Tom Liddell, Managing Director of Porvair Filtration Group stated, "For nearly 50 years we have [...]
Lucigen Corporation Awarded $1.7M in SBIR Grants
April 20, 2010
Lucigen Corporation is pleased to announce that it has recently been awarded three new grants to fund additional research and development. The National Institutes of Health has awarded Lucigen $1,764,732 in Small Business Innovation Research grants to be used over two years to develop research tools and diagnostic assays with potential to improve human health. [...]
